Abstract

Review Article

Maximizing the Potential of Ketogenic Dieting as a Potent, Safe, Easy-to-Apply and Cost-Effective Anti-Cancer Therapy

Simeon Ikechukwu Egba* and Daniel Chigbo

Published: 03 March, 2025 | Volume 9 - Issue 1 | Pages: 001-005

The global menace of cancer requires supplementary treatments beyond standard medical approaches for effective medical intervention. The Ketogenic Diet (KD) composed of high fats combined with moderate proteins and low carbohydrates has become popular as a metabolic therapy for cancer. The anti-cancer mechanism of KD works through metabolic stress induction in cancer cells, reduced insulin and IGF-1 signaling pathways, improved mitochondrial function, inflammation, and immune regulation. Standard cancer treatments receive enhanced outcomes through KD synergistic action which simultaneously decreases treatment-related side effects. To achieve optimized treatment outcomes in cancer, ketogenic diet practitioners need to use personalized nutritional planning in combination with metabolic tracking and exogenous ketone supplements. It is essential to find solutions for diet adherence issues and nutrient deficiencies because they determine KD’s effectiveness as a cancer treatment. The fight against cancer needs sustained and multipronged clinical research and validation to establish the proper implementation of this method.

Read Full Article HTML DOI: 10.29328/journal.acst.1001047 Cite this Article Read Full Article PDF

Keywords:

Ketogenic diet; Cancer therapy; Metabolic therapy; Ketosis; Oncology

References

  1. Debela DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC, et al. New approaches and procedures for cancer treatment: Current perspectives. SAGE Open Med. 2021;9:20503121211034366. Available from: https://doi.org/10.1177/20503121211034366
  2. Liu B, Zhou H, Tan L, Siu KTH, Guan XY. Exploring treatment options in cancer: tumor treatment strategies. Sig Transduct Target Ther. 2024;9:175. Available from: https://doi.org/10.1038/s41392-024-01856-7
  3. Mathew M, Nguyen NT, Bhutia YD, Sivaprakasam S, Ganapathy V. Metabolic signature of Warburg effect in cancer: An effective and obligatory interplay between nutrient transporters and catabolic/anabolic pathways to promote tumor growth. Cancers. 2024;16(3):504. Available from: https://doi.org/10.3390/cancers16030504
  4. Zhu H, Bi D, Zhang Y, Kong C, Du J, Wu X, et al. Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations. Sig Transduct Target Ther. 2022;7:11. Available from: https://doi.org/10.1038/s41392-021-00831-w
  5. Ahmad Y, Seo DS, Jang Y. Metabolic effects of ketogenic diets: Exploring whole-body metabolism in connection with adipose tissue and other metabolic organs. Int J Mol Sci. 2024;25(13):7076. Available from: https://doi.org/10.3390/ijms25137076
  6. Weber DD, Aminzadeh-Gohari S, Tulipan J, Catalano L, Feichtinger RG, Kofler B. Ketogenic diet in the treatment of cancer – Where do we stand? Mol Metab. 2020;33:102-121. Available from: https://doi.org/10.1016/j.molmet.2019.06.026
  7. Weber DD, Aminzadeh-Gohari S, Tulipan J, Catalano L, Feichtinger RG, Kofler B. Ketogenic diet in the treatment of cancer - Where do we stand? Mol Metab. 2020;33:102-121. Available from: https://doi.org/10.1016/j.molmet.2019.06.026
  8. Sun D, Gao W, Hu H, Zhou S. Why 90% of clinical drug development fails and how to improve it? Acta Pharm Sin B. 2022 Jul;12(7):3049-3062. Available from: https://doi.org/10.1016/j.apsb.2022.02.002
  9. Kong X, Gao P, Wang J, Fang Y, Hwang KC. Advances of medical nanorobots for future cancer treatments. J Hematol Oncol. 2023;16:74. Available from: https://doi.org/10.1186/s13045-023-01463-z
  10. Bose S, Zhang C, Le A. Glucose metabolism in cancer: The Warburg effect and beyond. In: Le A, editor. The Heterogeneity of Cancer Metabolism. Adv Exp Med Biol. 2021;1311:1-22. Available from: https://doi.org/10.1007/978-3-030-65768-0_1
  11. Jaworska M, Szczudło J, Pietrzyk A, Shah J, Trojan SE, Ostrowska B, et al. The Warburg effect: a score for many instruments in the concert of cancer and cancer niche cells. Pharmacol Rep. 2023;75:876-890. Available from: https://doi.org/10.1007/s43440-023-00504-1
  12. Menyhárt O, Győrffy B. Dietary approaches for exploiting metabolic vulnerabilities in cancer. Biochim Biophys Acta Rev Cancer. 2024;1879(2):189062. Available from: https://doi.org/10.1016/j.bbcan.2023.189062
  13. Xiao YL, Gong Y, Qi YJ, Shao ZM, Jiang YZ. Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential. Sig Transduct Target Ther. 2024;9:59. Available from: https://doi.org/10.1038/s41392-024-01771-x
  14. Gonzalez-Flores D, Gripo A-A, Rodríguez A-B, Franco L. Consequences of glucose enriched diet on oncologic patients. Appl Sci. 2023;13(5):2757. Available from: https://doi.org/10.3390/app13052757
  15. Kasprzak A. Insulin-like growth factor 1 (IGF-1) signaling in glucose metabolism in colorectal cancer. Int J Mol Sci. 2021;22(12):6434. Available from: https://doi.org/10.3390/ijms22126434
  16. Khan MZ, Zugaza JL, Torres Aleman I. The signaling landscape of insulin-like growth factor 1. J Biol Chem. 2025;301(1):108047. Available from: https://doi.org/10.1016/j.jbc.2024.108047
  17. Solarek W, Koper M, Lewicki S, Szczylik C, Czarnecka AM. Insulin and insulin-like growth factors act as renal cell cancer intratumoral regulators. J Cell Commun Signal. 2019;13:381-394. Available from: https://doi.org/10.1007/s12079-019-00512-y
  18. Kotsifaki A, Maroulaki S, Karalexis E, Stathaki M, Armakolas A. Decoding the role of insulin-like growth factor 1 and its isoforms in breast cancer. Int J Mol Sci. 2024;25(17):9302. Available from: https://doi.org/10.3390/ijms25179302
  19. Läsché M, Emons G, Gründker C. Shedding new light on cancer metabolism: A metabolic tightrope between life and death. Front Oncol. 2020;10:409. Available from: https://doi.org/10.3389/fonc.2020.00409
  20. Wang SF, Tseng LM, Lee HC. Role of mitochondrial alterations in human cancer progression and cancer immunity. J Biomed Sci. 2023;30:61. Available from: https://doi.org/10.1186/s12929-023-00956-w
  21. Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther. 2021;6(1):263. Available from: https://doi.org/10.1038/s41392-021-00658-5
  22. Cicchese JM, Evans S, Hult C, Joslyn LR, Wessler T, Millar JA, et al. Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology. Immunol Rev. 2018;285(1):147-167. Available from: https://doi.org/10.1111/imr.12671
  23. Moya-Garzon MD, Wang M, Li VL, Lyu X, Wei W, Tung AS, et al. A β-hydroxybutyrate shunt pathway generates anti-obesity ketone metabolites. Cell. 2025;188(1):175-186.e20. Available from: http://dx.doi.org/10.1016/j.cell.2024.10.032
  24. Chu J, Gao F, Yan M, Zhao S, Yan Z, Shi B, et al. Natural killer cells: a promising immunotherapy for cancer. J Transl Med. 2022;20:240. Available from: https://doi.org/10.1186/s12967-022-03437-0
  25. Wang MM, Coupland SE, Aittokallio T, Figueiredo CR. Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities. Br J Cancer. 2023;129:1212-1224. Available from: https://doi.org/10.1038/s41416-023-02361-4
  26. Duraj T, Kalamian M, Zuccoli G, Maroon JC, D’Agostino DP, Scheck AC, et al. Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma. BMC Med. 2024;22:578. Available from: https://doi.org/10.1186/s12916-024-03775-4
  27. Alpuim Costa D, Gonçalves-Nobre JG, Sampaio-Alves M, Guerra N, Arana Ribeiro J, et al. Hyperbaric oxygen therapy as a complementary treatment in neuroblastoma - a narrative review. Front Oncol. 2023;13:1254322. Available from: https://doi.org/10.3389/fonc.2023.1254322
  28. Picó C, Serra F, Rodríguez AM, Keijer J, Palou A. Biomarkers of nutrition and health: new tools for new approaches. Nutrients. 2019;11(5):1092. Available from: https://doi.org/10.3390/nu11051092
  29. Marino P, Mininni M, Deiana G, Marino G, Divella R, Bochicchio I, et al. Healthy lifestyle and cancer risk: Modifiable risk factors to prevent cancer. Nutrients. 2024;16(6):800. Available from: https://doi.org/10.3390/nu16060800
  30. Ghazizadeh E, Naseri Z, Deigner HP, Rahimi H, Altintas Z. Approaches of wearable and implantable biosensors towards developing in precision medicine. Front Med (Lausanne). 2024;11:1390634. Available from: https://doi.org/10.3389/fmed.2024.1390634
  31. Vo D-K, Trinh KTL. Advances in wearable biosensors for healthcare: Current trends, applications, and future perspectives. Biosensors. 2024;14(11):560. Available from: https://doi.org/10.3390/bios14110560
  32. Malinowska D, Żendzian-Piotrowska M. Ketogenic diet: A review of composition diversity, mechanism of action and clinical application. J Nutr Metab. 2024;2024:6666171. Available from: https://doi.org/10.1155/2024/6666171
  33. Kalam F, James DL, Li YR, Coleman MF, Kiesel VA, Cespedes Feliciano EM, et al. Intermittent fasting interventions to leverage metabolic and circadian mechanisms for cancer treatment and supportive care outcomes. J Natl Cancer Inst Monogr. 2023;2023(61):84-103. Available from: https://doi.org/10.1093/jncimonographs/lgad008
  34. Tiwari S, Sapkota N, Han Z. Effect of fasting on cancer: A narrative review of scientific evidence. Cancer Sci. 2022;113(10):3291-3302. Available from: https://doi.org/10.1111/cas.15492
  35. Fukazawa A, Koike A, Karasawa T, Tsutsui M, Kondo S, Terada S. Effects of a ketogenic diet containing medium-chain triglycerides and endurance training on metabolic enzyme adaptations in rat skeletal muscle. Nutrients. 2020;12(5):1269. Available from: https://doi.org/10.3390/nu12051269
  36. Fernández-Verdejo R, Mey JT, Ravussin E. Effects of ketone bodies on energy expenditure, substrate utilization, and energy intake in humans. J Lipid Res. 2023;64(10):100442. Available from: https://doi.org/10.1016/j.jlr.2023.100442
  37. Talib WH, Mahmod AI, Kamal A, Rashid HM, Alashqar AMD, Khater S, et al. Ketogenic diet in cancer prevention and therapy: Molecular targets and therapeutic opportunities. Curr Issues Mol Biol. 2021;43(2):558-589. Available from: https://doi.org/10.3390/cimb43020042
  38. Prudencio MB, de Lima PA, Murakami DK, Sampaio LPB, Damasceno NRT. Micronutrient supplementation needs more attention in patients with refractory epilepsy under ketogenic diet treatment. Nutrition. 2021;86:111158. Available from: https://doi.org/10.1016/j.nut.2021.111158
  39. Rollet M, Bohn T, Vahid F, On Behalf of The Oriscav Working Group. Association between dietary factors and constipation in adults living in Luxembourg and taking part in the ORISCAV-LUX 2 survey. Nutrients. 2021;14(1):122. Available from: https://doi.org/10.3390/nu14010122
  40. Crosby L, Davis B, Joshi S, Jardine M, Paul J, Neola M, et al. Ketogenic diets and chronic disease: Weighing the benefits against the risks. Front Nutr. 2021;8:702802. Available from: https://doi.org/10.3389/fnut.2021.702802
  41. Lane J, Brown NI, Williams S, Plaisance EP, Fontaine KR. Ketogenic diet for cancer: Critical assessment and research recommendations. Nutrients. 2021;13(10):3562. Available from: https://doi.org/10.3390/nu13103562
  42. Martínez-Garay C, Djouder N. Dietary interventions and precision nutrition in cancer therapy. Trends Mol Med. 2023;29(7):489-511. Available from: https://doi.org/10.1016/j.molmed.2023.04.004 

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?